Americas Opioid Epidemic

More documents

Recommendations

Info

References 1 Han B, Compton WM, Blanco C, et al. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey 10 Sederer LI: The Addiction Solution: Solving America’s Drug Crisis. New York, Scribner, in press [2018]. on Drug Use and Health. Ann Intern Med 167:293–301, 2017. Available at http://bit.ly/2udpA7P 11 Institute of Medicine: Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. Washington, DC, 2 Interim Report [draft]. Washington, DC, White House National Academies Press, 1994. Available at http://bit.ly/2yBmeC9 Commission on Combating Drug Addiction and the Opioid Crisis, 2017. Available at http://bit.ly/2weCCDw 12 LifeSkills Training Fact Sheet. White Plains, NY, National Health Promotion Associates, Inc. Available at http://bit.ly/2bkyFaJ 3 Barry C: Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policymakers Consider? Spring 2017 Paper Series. Philadelphia and Hudson, OH, Thomas Scattergood 13 Strengthening Families Program. Strengthening Families Foundation, no date. Available at http://bit.ly/1mbrJMg Behavioral Health Foundation and Margaret Clark Morgan Foundation, 2017. Available at http://bit.ly/2y4kqRB 14 Edwards VJ, Holden GW, Felitti VJ, et al.: Relationship between multiple forms of childhood maltreatment and adult mental 4 Provisional Counts of Drug Overdose Deaths, as of 8/6/2017. Atlanta, Centers for Disease Control and Prevention, National Center for Health Statistics, 2017. Available at health in community respondents: results from the Adverse Childhood Experiences Study. Am J Psychiatry 160:1453–1460, 2003. Available at http://bit.ly/2wJfcXq http://bit.ly/2wvMave 15 Trauma-Informed Care Resources Guide. Milwaukee, WI, Crisis 5 The Science of Drug Abuse and Addiction: The Basics. Prevention Institute, 2017. Available at http://bit.ly/2xsvLLL Bethesda, MD, National Institute on Drug Abuse, 2016. Available at http://bit.ly/2pDsvcz 16 About ParentCorps. New York, NYU Langone Health, Department of Population Health, 2017. Available at http://bit.ly/2g4MixQ 6 Popper N: Opioid dealers embrace the dark web to send deadly drugs by mail. NY Times, June 10, 2017. Available at http://nyti.ms/2t6DHLW 17 “Power Woman” Empowers Little. Tampa, FL, Big Brothers Big Sisters of America, 2017. Available at http://bit.ly/2g6x0c8 7 Chasin A: Assassin of Youth: A Kaleidoscopic History of Harry J. Anslinger’s War on Drugs. Chicago, University of Chicago Press, 2016. Available at http://bit.ly/2xtumo0 18 Alcohol Screening and Brief Intervention for Youth: A Practitioner’s Guide. Bethesda, MD, National Institute on Alcohol Abuse and Alcoholism, 2015. Available at http://bit.ly/2zaBfYI 8 Sederer L: Warning: This Drug May Kill You: an HBO documentary on the opioid epidemic, directed by Perri Peltz [blog post]. Psychol Today, Apr 23, 2017. Available at http://bit.ly/2i050aC 19 American Academy of Pediatrics: Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics 128(5):e1330–e1340, 2011. Available at http://bit.ly/2ybe8i7 9 The Opioid Effect: Inside Pennsylvania’s Heroin Epidemic [video]. New York, Tonic, Vice Media, LLC, 2016. Available at http://bit.ly/2y5ncG8 20 Weiss RD, Potter JS, Griffin ML, et al.: Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend 150:112–119, 2015. Available at http://bit.ly/2y8O7yF America’s Opioid Epidemic 20
21 Dole VP, Nyswander ME, Kreek MJ: Narcotic blockade. Arch 31 Nunes EV, Krupitsky E, Ling W, et al.: Treating opioid Intern Med 118:304–309, 1966. dependence with injectable extended-release naltrexone (XR-NTX): who will respond? J Addict Med 9:238–243, 2015. 22 Principles of Drug Addiction Treatment: A Research-Based Guide, Available at http://bit.ly/2hXPgF8 3rd ed.: Opioid Addiction: Methadone. Bethesda, MD, National Institute on Drug Abuse, 2012. Available at http://bit.ly/2dLb3hd 32 Murphy SM, Polsky D, Lee JD, et al.: Cost-effectiveness of extended-release naltrexone to prevent relapse among 23 Fullerton CA, Kim M, Thomas CP, et al.: Medication-assisted criminal justice–involved individuals with a history of opioid treatment with methadone: assessing the evidence. Psychiatr use disorder. Addiction 112:1140–1450, 2017. Available at Serv 65:146–157, 2014. Available at http://bit.ly/2y81fnF http://bit.ly/2wJke6v 24 Amato L, Davoli M, Perucci CA, et al.: An overview of systematic 33 The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to reviews of the effectiveness of opiate maintenance therapies: Opioid Treatment in Patients With Chronic Neuropathic available evidence to inform clinical practice and research. J Subst Pain [ClinicalTrials.gov Identifier NCT01840345]. Bethesda, Abuse Treat 28:321–329, 2005. Available at http://bit.ly/2y6bVFq MD, National Institutes of Health, ClinicalTrials.gov, 2017. Available at http://bit.ly/2y5uj1i 25 Whelan PJ, Remski K: Buprenorphine vs methadone treatment: a review of evidence in both developed and developing 34 Pollan M: The trip treatment. New Yorker, Feb 9, 2015. Available worlds. J Neurosci Rural Pract 3:45–50, 2012. Available at at http://bit.ly/2kCj0bu http://bit.ly/2yTYHbR 35 Mithoefer MC, Grob CS, Brewerton TD: Novel psychopharma- 26 Stein BD, Gordon AJ, Dick AW, et al.: Supply of buprenorphine cological therapies for psychiatric disorders: psilocybin waivered physicians: the influence of state policies. J Subst and MDMA. Lancet Psychiatry 3:481–488, 2016. Available at Abuse Treat 48:104–111, 2015. Available at http://bit.ly/2ybpW4B http://bit.ly/2yASHsf 27 Stein BD, Sorbero M, Dick AW, et al.: Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment. JAMA 316:1211–1212, 2016. Available at http://bit.ly/2ybilmx 28 Keilman J: Methadone patients fight heroin treatment stigma. Chicago Tribune, July 12, 2016. Available at http://trib.in/29PApFn 29 Principles of Harm Reduction. New York, Harm Reduction Coalition, no date. Available at http://bit.ly/1I4t27D 30 Krupitsky E, Nunes EV, Ling W, et al.: Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet 377:1506–1513, 2011. Available at http://bit.ly/2yc6yo7 36 37 38 White WL: Narcotics Anonymous and the Pharmacotherapeutic Treatment of Opioid Addiction in the United States. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011. Available at http://bit.ly/18AqkZQ Miller WR, Rollnick S: Motivational Interviewing: Preparing People for Change, 2nd ed. New York, Guilford Press, 2002 Principles of Drug Addiction Treatment: A Research-Based Guide, 3rd ed.: Cognitive-Behavioral Therapy (Alcohol, Marijuana, Cocaine, Methamphetamine, Nicotine). Bethesda, MD, National Institute on Drug Abuse, 2012. Available at http://bit.ly/2ybPC0o
Page 1 and 2: THINK BIGGER DO GOOD POLICY SERIES
Page 3 and 4: Dear Reader, Now is a time of chang
Page 5 and 6: Titles in the Paper Series Editors
Page 7 and 8: America’s Opioid Epidemic Lloyd I
Page 9 and 10: 2 Barriers to Solving the Epidemic
Page 11 and 12: The Center for Early Childhood Heal
Page 13 and 14: Psychedelic drugs (especially psilo
Page 15 and 16: 4 Other Considerations Two areas re
Page 17 and 18: The Economic Case The economic leg
Page 19: 6 Conclusion During Britain’s dar
Page 24: How to use this paper to “Think B

Americas Opioid Epidemic

Create successful ePaper yourself

Delete template?

Save as template?